Filings

4 documents · 45 matches

1. ABOS Acumen Pharmaceuticals, Inc. 10-Q 2026-10-26

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   that substantial doubt exists about our ability to continue as a going concern. See “Liquidity, Capital Resources and Going Concern.”
   10 matches in this document Show context Copy citation

2. ABOS Acumen Pharmaceuticals, Inc. 10-Q 2026-08-12

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   that substantial doubt exists about our ability to continue as a going concern. See “Liquidity, Capital Resources and Going Concern.”
   9 matches in this document Show context Copy citation

3. ABOS Acumen Pharmaceuticals, Inc. 10-Q 2026-05-12

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   that substantial doubt exists about our ability to continue as a going concern. See “Liquidity, Capital Resources and Going Concern.”
   9 matches in this document Show context Copy citation

4. ABOS Acumen Pharmaceuticals, Inc. 10-K 2026-03-26

   Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   that substantial doubt exists about our ability to continue as a going concern. See “Liquidity, Capital Resources and Going Concern.”
   17 matches in this document Show context Copy citation